Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
about
Gastric cancer: Current status of lymph node dissectionThe evolving role of catumaxomab in gastric cancerPemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, docetaxel, and cisplatin (modified DCF) in advanced gastric adenocarcinoma.Comparison of ultrasonic scalpel versus conventional techniques in open gastrectomy for gastric carcinoma patients: a systematic review and meta-analysis.Capecitabine in gastric cancer.Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysisPlatinum-based versus non-platinum-based chemotherapy as first line treatment of inoperable, advanced gastric adenocarcinoma: a meta-analysis.S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas.HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain.Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers.Gastrectomy and D2 Lymphadenectomy for Gastric Cancer: A Meta-Analysis Comparing the Harmonic Scalpel to Conventional Techniques.The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas.Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma.Emerging role of capecitabine in gastric cancer.HDM2 regulation by AURKA promotes cell survival in gastric cancer.Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.Metastatic gastric cancer treatment: a little slow but worthy progress.Perioperative chemotherapy in locally advanced gastric cancer.Laparoscopic gastrectomy for remnant gastric cancer: a comprehensive review and case series.Proximal gastrectomy versus total gastrectomy for proximal third gastric cancer: total gastrectomy is not always necessary.Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib.Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}.Multidisciplinary management of gastric and gastroesophageal cancers.A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer.Short-term outcomes of totally laparoscopic total gastrectomy: experience with the first consecutive 112 cases.Chemotherapy treatment patterns and neutropenia management in gastric cancer.Comparison of dosiology between three dimensional conformal and intensity-modulated radiotherapies (5 and 7 fields) in gastric cancer post-surgery.Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer.Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin).Gastric cancer: epidemiology, prevention, classification, and treatment.Laparoscopic gastrectomy for patients with a history of upper abdominal surgery: results of a matched-pair analysis.
P2860
Q26766091-8E362DE4-D99F-47E6-B964-B6B4E874A9A3Q28290511-B046BC08-ADE6-4150-BC3E-62C55F81C099Q33383287-4B6A28B6-9F8D-47C9-AA0B-91371ECBEDB6Q33403949-C15160CF-F991-4E21-A006-403A82478B3BQ33982124-CB08B0A2-4CC8-454C-8887-C785B6D94FE0Q34236005-1607F302-00CE-4423-B032-FA29D108DAC9Q34255463-5DFC63D6-F924-4452-80C5-ECE15C03F3E6Q34479911-657C34F1-D045-477C-86F7-8D78146FE385Q34672942-C9915432-9C7F-4576-985E-961140ADB35AQ34852173-EA244E6F-FFDF-409C-B0C7-9E0493D74EB8Q35070531-1A0D540B-4827-4946-A429-0DCCEB7A2C90Q35146597-7AB49876-6898-433B-B9FC-320CD27BA37DQ35181089-F8910668-8C21-41DC-B79E-CE7AB30F3C10Q35495307-C526D07E-B158-4921-99EF-4206AE3AB5FEQ35583933-0C7851D6-4809-4B6F-906F-DC9CE45C52D3Q35657048-F411B369-99C2-4797-BECD-D7C779AB4B11Q36472693-D56A6EBC-0DEC-43F2-9C1B-77082714B2E9Q37134006-E5558C5C-56E2-4693-912F-F1C115159238Q37403462-331CE61B-2229-4B08-BB4E-9544BE0258FDQ37626244-E842701D-6024-4E61-8B1F-700AA863F436Q37648073-398A7B85-AE3E-42E5-9EC3-82BE44392024Q37687566-BAB82A48-0810-424A-859D-03C4A3B8CAB5Q38075499-177F4E44-55E1-488A-A68C-B8559B976525Q38169894-3EA6B1B6-347D-41AA-9B8D-BDD55901A1E8Q38287338-3B51BE36-1F77-4EA5-8708-3DB70916BBF0Q38824833-8D9C652F-6182-427D-A63F-65F53A531C52Q38833185-428F9F36-48AA-40B0-A9EC-E18B26D0A54EQ39933959-FB519C5B-E65C-4D53-9896-D48CB27C0B1FQ40282337-DD697D87-7056-4CB0-9434-A4FC9E0320BFQ43058727-BFD0A924-CEB6-45C9-B92E-C5783204DACAQ43830000-000A8B88-BD9E-46F7-908A-4EF6758A154CQ44709529-ACCD793A-DD79-4FBC-9932-7C49E7902033Q46057636-CFB443F2-2A43-4829-B4A2-FB6E9013BE36Q46892007-4C753265-1329-4675-BE12-1920B7D55FACQ47969105-5FE1602D-2877-4F34-A86E-D3A7B7888F22Q48083144-764F2597-F6EC-48E6-8FA9-4716A20F43C6Q49702243-7623CCC2-BBCD-4B44-93E1-EB5618900381Q50191726-0FEDC7CF-FA83-4498-8295-3BB3DBCB988F
P2860
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expert opinion on management o ...... gastrointestinal cancer group.
@en
Expert opinion on management o ...... search and Treatment of Cancer
@nl
type
label
Expert opinion on management o ...... gastrointestinal cancer group.
@en
Expert opinion on management o ...... search and Treatment of Cancer
@nl
prefLabel
Expert opinion on management o ...... gastrointestinal cancer group.
@en
Expert opinion on management o ...... search and Treatment of Cancer
@nl
P2093
P1476
Expert opinion on management o ...... gastrointestinal cancer group.
@en
P2093
Arnaud Roth
Cornelius Van de Velde
European Organisation for Rese ...... -gastrointestinal cancer group
Florian Lordick
Matti Aapro
Stefano Cascinu
P304
P356
10.1016/J.EJCA.2007.11.001
P577
2008-01-01T00:00:00Z